Remdesivir reduces Covid hospitalizations when given early, study shows
(By Matthew Herper for STAT) Gilead’s Covid-19 drug remdesivir appeared to reduce hospitalizations by 87% in high-risk patients diagnosed early
Read More(By Matthew Herper for STAT) Gilead’s Covid-19 drug remdesivir appeared to reduce hospitalizations by 87% in high-risk patients diagnosed early
Read More(By Maia Anderson for Becker’s Hospital Review) The HHS Health Resources & Services Administration sent letters to six drugmakers Sept.
Read More(By Daniel R. George and Peter Whitehouse for STAT) Billions of dollars have been spent in pursuit of a pharmaceutical
Read More(By Alia Paavola for Becker’s Hospital Review) Less than 5 percent of the U.S. population accounted for half of healthcare
Read More(By Scott Hensley for NPR) The Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine
Read More(By Michelle Andrews for Kaiser Health News) It took years for Elle Moxley to get a diagnosis that explained her
Read More(By Matthew Herper for STAT) Johnson & Johnson said Tuesday that a large, global study showed its Covid-19 vaccine is
Read More(Source – www.medicare.gov/blog) The next Medicare Open Enrollment Period (October 15 – December 7) is coming fast, which means con
Read More(By Rachel Cohrs for STAT) WASHINGTON — House Speaker Nancy Pelosi’s aggressive drug pricing package failed a key committee vote
Read MoreWhat to do when Medicare does not cover the drug your doctor ordered? It is vital to understand what drug
Read More